Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
New drug cocktail shows promise for Tough-to-Treat throat cancer
Disease control CompletedThis study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) followed by standard chemoradiation in 60 people with advanced nasopharyngeal cancer, a type of throat cancer common in southern China. The goal was to see if the new drug comb…
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 26, 2026 11:41 UTC
-
New combo therapy shows promise for inoperable liver cancer
Disease control CompletedThis study tested a new combination treatment for people with liver cancer that cannot be removed by surgery. The treatment included chemotherapy delivered directly to the liver, a procedure to block the tumor's blood supply, and two drugs (lenvatinib and tislelizumab). The goal …
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 26, 2026 11:09 UTC